New drug slows down the spread of breast cancer

A recent medical study revealed that a new drug for breast cancer can slow the disease for three months and have fewer side effects.

The experimental drug, known as “TDM1,” works against the most aggressive type of breast cancer, and the drug “Herceptin” is mixed with chemotherapy in one dose, and trials have shown that the new drug prevents advanced breast cancer from getting worse for three months compared to the standard treatment. At the same time, it reduces the debilitating side effects of chemotherapy.

This drug is considered the first of its kind for breast cancer and works by attaching to a part of the carcinogenic cell and preventing it from growing and spreading, while making its way to the cell at the same time and releasing a toxic chemotherapy from the inside.

In the trial of nearly 2 people with advanced HER1-positive cancer, four out of ten patients responded to TDMXNUMX, compared to less than a third of those who were on standard treatment.

Professor Paul Ellis from Guy's Hospital in London said: 'These findings are noteworthy because for the first time in breast cancer, we have been able to greatly improve efficacy while simultaneously reducing many of the unpleasant side effects associated with chemotherapy.

For her part, the Director of the British Breast Cancer Research Society, Dr. Lisa Wild This study is a positive development for patients with advanced HER2 breast cancer who currently have limited treatment options.

Fortunately, breast cancer is one of the cancers that can be treated permanently if detected early, and this is what we call for all women over 25 years of age.